Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM

N. Ripin, J. Boudet, MM. Duszczyk, A. Hinniger, M. Faller, M. Krepl, A. Gadi, RJ. Schneider, J. Šponer, NC. Meisner-Kober, FH. Allain,

. 2019 ; 116 (8) : 2935-2944. [pub] 20190204

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027852
E-zdroje Online Plný text

NLK Free Medical Journals od 1915 do Před 6 měsíci
Freely Accessible Science Journals od 1915 do Před 6 měsíci
PubMed Central od 1915 do Před 6 měsíci
Europe PubMed Central od 1915 do Před 6 měsíci
Open Access Digital Library od 1915-01-15
Open Access Digital Library od 1915-01-01

Human antigen R (HuR) is a key regulator of cellular mRNAs containing adenylate/uridylate-rich elements (AU-rich elements; AREs). These are a major class of cis elements within 3' untranslated regions, targeting these mRNAs for rapid degradation. HuR contains three RNA recognition motifs (RRMs): a tandem RRM1 and 2, followed by a flexible linker and a C-terminal RRM3. While RRM1 and 2 are structurally characterized, little is known about RRM3. Here we present a 1.9-Å-resolution crystal structure of RRM3 bound to different ARE motifs. This structure together with biophysical methods and cell-culture assays revealed the mechanism of RRM3 ARE recognition and dimerization. While multiple RNA motifs can be bound, recognition of the canonical AUUUA pentameric motif is possible by binding to two registers. Additionally, RRM3 forms homodimers to increase its RNA binding affinity. Finally, although HuR stabilizes ARE-containing RNAs, we found that RRM3 counteracts this effect, as shown in a cell-based ARE reporter assay and by qPCR with native HuR mRNA targets containing multiple AUUUA motifs, possibly by competing with RRM12.

000      
00000naa a2200000 a 4500
001      
bmc19027852
003      
CZ-PrNML
005      
20190815112746.0
007      
ta
008      
190813s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1073/pnas.1808696116 $2 doi
035    __
$a (PubMed)30718402
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ripin, Nina $u Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland; nina.ripin@mol.biol.ethz.ch nicole.meisner-kober@sbg.ac.at frederic.allain@mol.biol.ethz.ch. Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.
245    10
$a Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM / $c N. Ripin, J. Boudet, MM. Duszczyk, A. Hinniger, M. Faller, M. Krepl, A. Gadi, RJ. Schneider, J. Šponer, NC. Meisner-Kober, FH. Allain,
520    9_
$a Human antigen R (HuR) is a key regulator of cellular mRNAs containing adenylate/uridylate-rich elements (AU-rich elements; AREs). These are a major class of cis elements within 3' untranslated regions, targeting these mRNAs for rapid degradation. HuR contains three RNA recognition motifs (RRMs): a tandem RRM1 and 2, followed by a flexible linker and a C-terminal RRM3. While RRM1 and 2 are structurally characterized, little is known about RRM3. Here we present a 1.9-Å-resolution crystal structure of RRM3 bound to different ARE motifs. This structure together with biophysical methods and cell-culture assays revealed the mechanism of RRM3 ARE recognition and dimerization. While multiple RNA motifs can be bound, recognition of the canonical AUUUA pentameric motif is possible by binding to two registers. Additionally, RRM3 forms homodimers to increase its RNA binding affinity. Finally, although HuR stabilizes ARE-containing RNAs, we found that RRM3 counteracts this effect, as shown in a cell-based ARE reporter assay and by qPCR with native HuR mRNA targets containing multiple AUUUA motifs, possibly by competing with RRM12.
650    _2
$a 3' nepřekládaná oblast $7 D020413
650    _2
$a úseky bohaté na AU $x genetika $7 D063307
650    _2
$a krystalografie rentgenová $7 D018360
650    _2
$a dimerizace $7 D019281
650    _2
$a encefalomyelitida paraneoplastická - Hu antigeny $x chemie $7 D051959
650    _2
$a HuR protein $x chemie $x genetika $7 D000067780
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční spektroskopie $7 D009682
650    _2
$a motiv rozpoznávající RNA $x genetika $7 D000071377
650    _2
$a proteiny vázající RNA $x chemie $x genetika $7 D016601
650    _2
$a ribonukleosiddifosfátreduktasa $x chemie $7 D012262
650    _2
$a nádorové supresorové proteiny $x chemie $7 D025521
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Boudet, Julien $u Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland.
700    1_
$a Duszczyk, Malgorzata M $u Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland.
700    1_
$a Hinniger, Alexandra $u Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.
700    1_
$a Faller, Michael $u Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.
700    1_
$a Krepl, Miroslav $u Institute of Biophysics, Czech Academy of Sciences, 612 65 Brno, Czech Republic. Department of Physical Chemistry, Faculty of Science, Regional Centre of Advanced Technologies and Materials, Palacky University Olomouc, 771 46 Olomouc, Czech Republic.
700    1_
$a Gadi, Abhilash $u Department of Microbiology, New York University School of Medicine, New York, NY 10016.
700    1_
$a Schneider, Robert J $u Department of Microbiology, New York University School of Medicine, New York, NY 10016.
700    1_
$a Šponer, Jiří $u Institute of Biophysics, Czech Academy of Sciences, 612 65 Brno, Czech Republic. Department of Physical Chemistry, Faculty of Science, Regional Centre of Advanced Technologies and Materials, Palacky University Olomouc, 771 46 Olomouc, Czech Republic.
700    1_
$a Meisner-Kober, Nicole C $u Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland; nina.ripin@mol.biol.ethz.ch nicole.meisner-kober@sbg.ac.at frederic.allain@mol.biol.ethz.ch.
700    1_
$a Allain, Frédéric H-T $u Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland; nina.ripin@mol.biol.ethz.ch nicole.meisner-kober@sbg.ac.at frederic.allain@mol.biol.ethz.ch.
773    0_
$w MED00010472 $t Proceedings of the National Academy of Sciences of the United States of America $x 1091-6490 $g Roč. 116, č. 8 (2019), s. 2935-2944
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30718402 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190815113013 $b ABA008
999    __
$a ok $b bmc $g 1433001 $s 1066312
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 116 $c 8 $d 2935-2944 $e 20190204 $i 1091-6490 $m Proceedings of the National Academy of Sciences of the United States of America $n Proc Natl Acad Sci U S A $x MED00010472
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...